Stan J. F. Hartman

The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study

Bianca D. van Groen, Elke H. J. Krekels, Miriam G. Mooij et al. · Clinical Pharmacology & Therapeutics · 2020 · 30 citations · Full text

Pharmacy, Pediatrics, Pharmacology +15

Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study

Stan J. F. Hartman, Parth J. Upadhyay, Nienke N. Hagedoorn et al. · Clinical Pharmacokinetics · 2021 · 21 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Risk factors for intensive care admission in children with severe acute asthma in the Netherlands: a prospective multicentre study

Shelley A. Boeschoten, Annemie L. M. Boehmer, Peter Merkus et al. · ERJ Open Research · 2020 · 19 citations · Full text

Public Health, Child Health, Pediatrics +13

External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study

Stan J. F. Hartman, Lynn B. Orriëns, Samanta M. Zwaag et al. · Pediatric Drugs · 2020 · 18 citations · Full text

Pharmacy, Pediatrics, Pharmacokinetics +17

A New Framework to Implement Model-Informed Dosing in Clinical Guidelines: Piperacillin and Amikacin as Proof of Concept

Stan J. F. Hartman, Joost G. E. Swaving, Stijn W. van Beek et al. · Frontiers in Pharmacology · 2020 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17